| Josjin Vazhappilly, | |
|
2007 Tidewater Colony Dr, Suite 1 A, Annapolis, MD 21401-2101 | |
| (443) 949-0814 | |
| (443) 949-0825 |
| Full Name | Josjin Vazhappilly |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 2007 Tidewater Colony Dr, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851520936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | D0071199 (Maryland) | Primary |
| 207R00000X | Internal Medicine | D0071199 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Southern Maryland Hospital Center | Clinton, MD | Hospital |
| Sagepoint Nursing And Rehabilitation Center | La plata, MD | Nursing home |
| Waldorf Center | Waldorf, MD | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gps Physician Group, Pc | 9739447400 | 70 |
| Genesis Eldercare Physician Services Llc | 9830002534 | 41 |
News Archive
Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.
Using the new gene-editing enzyme CRISPR-Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab.
Researchers at the University of Birmingham have developed a new way to identify patients with heart failure who will benefit from treatment with beta-blockers.
A new study indicates there may be yet another reason to reduce childhood obesity - it may help prevent allergies. The study published in the May issue of the Journal of Allergy and Clinical Immunology showed that obese children and adolescents are at increased risk of having some kind of allergy, especially to a food.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 8 days ago
| Entity Name | Genesis Eldercare Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881635183 PECOS PAC ID: 9830002534 Enrollment ID: O20050124000329 |
News Archive
Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.
Using the new gene-editing enzyme CRISPR-Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab.
Researchers at the University of Birmingham have developed a new way to identify patients with heart failure who will benefit from treatment with beta-blockers.
A new study indicates there may be yet another reason to reduce childhood obesity - it may help prevent allergies. The study published in the May issue of the Journal of Allergy and Clinical Immunology showed that obese children and adolescents are at increased risk of having some kind of allergy, especially to a food.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 8 days ago
| Entity Name | Mdics Rehabilitative Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124313309 PECOS PAC ID: 4981861903 Enrollment ID: O20120206000334 |
News Archive
Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.
Using the new gene-editing enzyme CRISPR-Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab.
Researchers at the University of Birmingham have developed a new way to identify patients with heart failure who will benefit from treatment with beta-blockers.
A new study indicates there may be yet another reason to reduce childhood obesity - it may help prevent allergies. The study published in the May issue of the Journal of Allergy and Clinical Immunology showed that obese children and adolescents are at increased risk of having some kind of allergy, especially to a food.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 8 days ago
| Entity Name | Mdics At Civista Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225323496 PECOS PAC ID: 8325200793 Enrollment ID: O20120501000281 |
News Archive
Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.
Using the new gene-editing enzyme CRISPR-Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab.
Researchers at the University of Birmingham have developed a new way to identify patients with heart failure who will benefit from treatment with beta-blockers.
A new study indicates there may be yet another reason to reduce childhood obesity - it may help prevent allergies. The study published in the May issue of the Journal of Allergy and Clinical Immunology showed that obese children and adolescents are at increased risk of having some kind of allergy, especially to a food.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 8 days ago
| Entity Name | Gps Physician Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881109452 PECOS PAC ID: 9739447400 Enrollment ID: O20180117001189 |
News Archive
Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.
Using the new gene-editing enzyme CRISPR-Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab.
Researchers at the University of Birmingham have developed a new way to identify patients with heart failure who will benefit from treatment with beta-blockers.
A new study indicates there may be yet another reason to reduce childhood obesity - it may help prevent allergies. The study published in the May issue of the Journal of Allergy and Clinical Immunology showed that obese children and adolescents are at increased risk of having some kind of allergy, especially to a food.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Josjin Vazhappilly, 2007 Tidewater Colony Dr, Suite 1 A, Annapolis, MD 21401-2101 Ph: (443) 949-0814 | Josjin Vazhappilly, 2007 Tidewater Colony Dr, Suite 1 A, Annapolis, MD 21401-2101 Ph: (443) 949-0814 |
News Archive
Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.
Using the new gene-editing enzyme CRISPR-Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab.
Researchers at the University of Birmingham have developed a new way to identify patients with heart failure who will benefit from treatment with beta-blockers.
A new study indicates there may be yet another reason to reduce childhood obesity - it may help prevent allergies. The study published in the May issue of the Journal of Allergy and Clinical Immunology showed that obese children and adolescents are at increased risk of having some kind of allergy, especially to a food.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 8 days ago
Gashaw Adugna Dadi, M.D Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 240-495-4189 | |
Dr. Eugene Thomas Manion, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 900 Bestgate Road, Suite 303, Annapolis, MD 21401 Phone: 410-224-8220 Fax: 410-841-2482 | |
Dr. Lisa A Dimarzio, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Parkway, Suite 100, Annapolis, MD 21401 Phone: 410-573-1110 Fax: 410-266-0714 | |
Dr. Richard A Bernstein, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Defense Hwy, Suite 109, Annapolis, MD 21401 Phone: 401-224-5558 Fax: 410-224-7321 | |
Dr. Jonathan A Altschuler, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Ste 500, Annapolis, MD 21401 Phone: 410-573-6480 Fax: 410-573-9413 | |
Dr. Ira M Weinstein, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 607, Annapolis, MD 21401 Phone: 410-266-1644 Fax: 410-266-1642 | |
Dr. James M Blake, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 Bestgate Road, Suite 2a, Annapolis, MD 21401 Phone: 410-224-2116 Fax: 410-224-2118 |